Novartis: all 3,900 studies
Page 1 of 39. Open to participants first (226), then studies with results posted, then the rest; newest registration first within each.
- A Study Characterizing the Elevated Liver Enzymes in Ribociclib Treated HR+ HER2- Advanced Breast Cancer Patients Using a Machine Learning Approach With Real-world DataNot yet recruitingNCT07945548
- A Safety and Tolerability Study of HJB647 in Adult Participants With Uncontrolled HypertensionNot yet recruitingNCT07940647Phase 1
- A Study to Assess the Effect of Pacibekitug on Major Cardiovascular Events in Patients After a Myocardial InfarctionNot yet recruitingNCT07938411Phase 3
- A Study of Real-world Effectiveness of 177Lu-PSMA-617 With and Without Concurrent Androgen Receptor Pathway Inhibitors in Metastatic Castration Resistant Prostate Cancer PatientsNot yet recruitingNCT07928037
- Extension Study of Safety and Tolerability of DDY391 in Participants With Moderate to Severe Psoriatic Arthritis (CDDY391A12201-extension)Not yet recruitingNCT07923773Phase 2
- An Ascending Dose Study of DKB903 in Participants With Rheumatoid Arthritis (RA) and Participants With Systemic Lupus Erythematosus (SLE)Not yet recruitingNCT07923747Phase 1
- Remibrutinib in Real-world Clinical Practice - a South Korea Sub-StudyNot yet recruitingNCT07920315
- A Study to Assess the Safety, Tolerability and Pharmacokinetics of XEP527 in Patients With Stable SchizophreniaRecruitingNCT07908680Phase 1
- A Study of TRB191 in Patients With Extensive-stage Small Cell Lung CancerRecruitingNCT07908667Phase 1
- Factors Influencing Adoption of a Novel Malaria Treatment in Côte d'Ivoire, Ghana, and RwandaNot yet recruitingNCT07896746
- A Real-world Study of Treatment Retention and Adherence to Secukinumab in Patients With Plaque Psoriasis (PsO) With or Without Glucagon-like Peptide-1 Receptor Agonist (GLP-1 RA) Co-therapyNot yet recruitingNCT07881783
- A Study to Evaluate the Safety, Tolerability and Pharmacodynamics of NIO752 in Primary TauopathiesNot yet recruitingNCT07868328Phase 2
- A Study to Explore the Tissue Level Effects of Remibrutinib in Adults With Moderate to Severe HSRecruitingNCT07855276Phase 1
- A Study of the Efficacy and Safety of Zigakibart + Atrasentan in Adult Patients With Primary IgA NephropathyNot yet recruitingNCT07850752Phase 3
- Dose-finding Study of YMI024 to Assess Efficacy, Safety, and Tolerability in Adults With Stable Coronary Artery Disease and Elevated hsCRPRecruitingNCT07830719Phase 2
- Investigation of a Remibrutinib- and Omalizumab-based Treatment Algorithm in Adult Patients With Chronic Spontaneous Urticaria Inadequately Controlled by H1-antihistamines Within 24 WeeksRecruitingNCT07816328Phase 3
- Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Participants With Uncomplicated Plasmodium Falciparum Malaria (Cohort C2)RecruitingNCT07811908Phase 2
- A Study to Evaluate Efficacy, Safety, and Tolerability of Remibrutinib in Adult Participants With Severe Chronic Pruritus of Unknown Origin (CPUO)RecruitingNCT07811869Phase 3
- A Study of [68Ga]Ga-DWJ155 in Adult Patients With Solid TumorsRecruitingNCT07801508Phase 1
- A Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Moderate to Severe Psoriatic ArthritisRecruitingNCT07801495Phase 2
- A Study to Investigate the Pharmacokinetics and Safety of PKN605 in Participants With Moderate and Severe Renal Impairment Compared to Matched Control Subjects With Normal Renal FunctionRecruitingNCT07797322Phase 1
- A Study of Patients' Preferences for Primary Immune Thrombocytopenia TreatmentRecruitingNCT07786077
- A Drug-drug Interaction Study to Assess the Effect of Phenytoin and Itraconazole on the Pharmacokinetics of Pelabresib in Healthy ParticipantsRecruitingNCT07783503Phase 1
- A Study Comparing Effectiveness of Kesimpta® (Ofatumumab) Versus Ocrevus® (Ocrelizumab) in Real-world PracticeRecruitingNCT07779460
- A Study to Assess the Efficacy and Safety of GIA632 Across a Range of Doses in Participants With Moderate to Severe Cutaneous Lichen PlanusRecruitingNCT07775924Phase 2
- A Real-World Study of Second-line Therapies Among Radioiodine-refractory Differentiated Thyroid Cancer (RAI-R DTC) PatientsNot yet recruitingNCT07770074
- A 52-week Study of Remibrutinib in IgE-mediated Food AllergyRecruitingNCT07768371Phase 3
- A Study of the Safety and Effectiveness of Onasemnogene Abeparvovec (Zolgensma) Intrathecal Injection in Spinal Muscular Atrophy PatientsRecruitingNCT07767890
- A Study of Clinical Practice and Real-world Care of Patients Treated With mTOR, PI3K, and MEK Inhibitors for Extracranial Vascular AnomaliesNot yet recruitingNCT07767877
- A 52-Week Study Evaluating the Efficacy and Safety of Arumakimig (MAS825) in Participants With VEXAS Followed by Open-Label Extension (OLE) PeriodRecruitingNCT07748624Phase 2
- Study to Evaluate the effIcacy and Safety of Abelacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral AnticoagulationNot yet recruitingNCT07739888Phase 3
- A Real-World Medical Chart Review of Spinal Muscular Atrophy Patients Treated With Onasemnogene Abeparvovec in Saudi ArabiaNot yet recruitingNCT07737756
- A Phase 2a/b Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Sjögren's DiseaseRecruitingNCT07737743Phase 2
- A Study to Assess the Safety of Subcutaneous Secukinumab for Treatment in Adult Indian Participants With Axial Spondyloarthritis (axSpA), Ankylosing Spondylitis (AS), and Non-Radiographic Axial Spondyloarthritis (nr-axSpA)Not yet recruitingNCT07737730
- A Study to Characterize the Clinical Presentation and Course of Cryptosporidium in Pediatric ParticipantsRecruitingNCT07716410
- Study to Assess Safety and Clinical Responses With Coartem® Baby Dispersible Tablets in Paediatric Patients Weighing 2 to <5 kg With Uncomplicated MalariaNot yet recruitingNCT07713602Phase 4
- A Study to Evaluate Efficacy, Safety and Tolerability of Remibrutinib in Adult Participants With Severe Chronic Pruritus of Unknown Origin (CPUO)RecruitingNCT07700056Phase 3
- Pluvicto Real-world Investigation in Survival in Metastatic CRPCRecruitingNCT07697989
- A Study of Early Secukinumab Treatment in Moderate to Severe Hidradenitis Suppurativa PatientsNot yet recruitingNCT07690319
- Comparative Assessment of Inclisiran on Top of Standard of Care Versus Standard of Care Alone for LDL-C Evaluation in Acute Coronary Syndrome Patients in Saudi ArabiaNot yet recruitingNCT07684469Phase 4
- A Study to Estimate Secukinumab Retention Rate in Psoriasis Patients With MASLDRecruitingNCT07683065
- A Phase 2 Study to Investigate the Efficacy, Safety and Tolerability of Remibrutinib (LOU064) in Adult Patients With Papulopustular Rosacea (PPR)RecruitingNCT07681271Phase 2
- A Study of Asciminib Safety and Efficacy in Young Adults With Chronic Myeloid Leukemia in the Gulf RegionNot yet recruitingNCT07681258
- Roll-Over Study of Alpelisib (BYL719) for Continued Access and Long-Term Safety.Not yet recruitingNCT07679269Phase 2
- A Study of Real-World Characteristics, Treatment Patterns, and Outcomes Among mCRPC Patients Previously Treated With an Androgen Receptor Pathway Inhibitor, Taxane-Based Chemotherapy, and Lutetium-177 Vipivotide TetraxetanRecruitingNCT07677267
- A Study of Real-World Characteristics, Treatment Patterns, and Clinical Outcomes in Patients With Metastatic Castration-Resistant Prostate CancerRecruitingNCT07677254
- An Extension Study to Assess Safety and Efficacy of Remibrutinib in Participants With Moderate to Severe HSRecruitingNCT07665437Phase 3
- A Study of Ianalumab in Addition to Eltrombopag in Pediatric Patients With Primary ITP Who Failed Corticosteroids.Not yet recruitingNCT07660172Phase 2
- Study of [177Lu]Lu-DWJ155 and [68Ga]Ga-DWJ155 in Patients With Solid TumorsRecruitingNCT07660055Phase 1
- HJB647 Phase 1b Study in Japanese Healthy Participants With Elevated Blood Pressure and Patients With HypertensionRecruitingNCT07644364Phase 1
- Remibrutinib in Real-world Clinical Practice - a Germany Sub-study (REASSERT)RecruitingNCT07642557
- A Study of Treatment Patterns and Outcomes in Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET) PatientsRecruitingNCT07635316
- Phase I Study of JFI447 [68Ga]Ga-DFC413 and Comparison to FFG233 [68Ga]Ga-NNS309 in Patients With Solid TumorsRecruitingNCT07630961Phase 1
- Assessment of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a New Formulation of Inclisiran Containing Polysorbate 80 Compared to the Currently Marketed FormulationRecruitingNCT07626281Phase 1
- Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom BurdenRecruitingNCT07621809Phase 3
- A Study to Evaluate the Pharmacodynamics of a Combination of QCZ484 and Inclisiran in Participants With Hypertension and Concomitant HypercholesterolemiaRecruitingNCT07610278Phase 2
- Study of IEV407 as Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast CancerRecruitingNCT07604571Phase 1
- A First-in-human Study to Investigate Single Doses of DCY636 in Healthy Volunteers and Multiple Doses in Participants With Moderate to Severe Atopic DermatitisRecruitingNCT07604324Phase 1
- A Study of Complement 3 Glomerulopathy (C3G) Patients Treated With Iptacopan Through an Early Access Program in SpainRecruitingNCT07598448
- A Study to Assess the Effectiveness and Safety of Canakinumab in Clinical Use in Patients With Schnitzler's SyndromeRecruitingNCT07598422
- A Study of Ruxolitinib in Patients With Graft-Versus Host DiseaseRecruitingNCT07594587
- A Real-world Study of Treatment Patterns and Outcomes in Primary Immune Thrombocytopenia Patients Treated With EltrombopagRecruitingNCT07587723
- A Phase 3 Study to Evaluate the Safety and Efficacy of AOC 1044 (Also Referred to as Delpacibart Zotadirsen) in Participants With DMD With Gene Mutations Amenable to Exon 44 SkippingRecruitingNCT07587242Phase 3
- A Study to Investigate the Safety and Tolerability of Oral INR731 Single Agent or in Combination With Androgen Receptor Pathway Inhibitor (ARPI) in Patients With Metastatic Prostate CancerRecruitingNCT07570979Phase 1
- A Study to Evaluate DJI136, a DLL3-targeted CAR-T TherapyRecruitingNCT07564401Phase 1/2
- A Study on the Tolerability, Safety and Effectiveness of Asciminib in Patients With Philadelphia Chromosome-positive Chronic Myeloid Leukemia in the Chronic Phase in GermanyRecruitingNCT07549516
- A Real-World Study of Long-Term Adherence and Persistence to Inclisiran, Evolocumab, and AlirocumabRecruitingNCT07543731
- Long Term Observational Study to Collect in a Real-world populatIon Data on the Treatment Pattern of Secukinumab in Adult Patients With Moderate to Severe HS Within the Italian PopulationRecruitingNCT07543419
- An Open-label Extension Safety and Efficacy Study of QCZ484 in Hypertensive Patients.RecruitingNCT07543120Phase 2
- A Study on the Use of Canakinumab Among Familial Mediterranean Fever and Still's Disease PatientsRecruitingNCT07517250
- Impact of Implementation Strategies on Lp(a) Testing in Secondary Care SettingsRecruitingNCT07508007
- A Study to Evaluate the Efficacy of NIO752 in Participants With Progressive Supranuclear PalsyRecruitingNCT07498426Phase 3
- Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Atrasentan in Pediatric Patients With Primary IgANRecruitingNCT07498335Phase 3
- Study of Efficacy and Safety of Secukinumab in Chinese Adult Patients With Moderate to Severe Hidradenitis SuppurativaRecruitingNCT07489573Phase 4
- PULSE Registry: for Patients Receiving Lutetium (177Lu) Vipivotide TetraxetanRecruitingNCT07484269
- IgA Nephropathy Insights From Treatment Experience Among Patients Receiving Iptacopan and/or Atrasentan Using Primary Data CollectionNot yet recruitingNCT07481084
- Real-World Treatment Pattern and Clinical Outcome With Influential Factors of HR+/HER2-aBC 1L Patients in ChinaRecruitingNCT07476170
- Real World Adherence of PCSK9 Targeted TherapyNot yet recruitingNCT07468500
- Study to Assess the Safety, Tolerability, and Treatment Response of GXV813 in Hospitalized Adults With SchizophreniaRecruitingNCT07467993Phase 2
- A Real-world Study of the Effectiveness of Angiotensin Receptor-Neprilysin Inhibitor Therapy in Hypertensive Patients in the United Arab EmiratesRecruitingNCT07465666
- A Safety and Tolerability Study of HJB647 in Heart Failure Participants With Reduced Ejection FractionRecruitingNCT07465653Phase 1
- Remibrutinib Open Label Roll-over Post-trial Access ProtocolRecruitingNCT07456891Phase 3
- A Real-world Study of Patients With Hidradenitis Suppurativa and High Cardiovascular Risk or Established Coronary Plaque Treated With SecukinumabNot yet recruitingNCT07454889
- A Study of Patient Characteristics, Co-Morbidities, and Treatment Patterns in Chronic Myeloid Leukemia Patients in KuwaitNot yet recruitingNCT07454850
- ASsessing The REAl-world Safety & Effectiveness of Spinal Muscular Atrophy Participants Treated With Intrathecal Onasemnogene Abeparvovec-brve (OAV101B) (ITVISMA®): A U.S. Pragmatic Multicenter Study (STREAM)RecruitingNCT07448610Phase 4
- A Study to Investigate Efficacy and Safety of FWY003 Compared With Placebo in Participants With Geographic Atrophy Secondary to Age-related Macular DegenerationRecruitingNCT07441642Phase 2
- A Phase IIb Dose-ranging Study to Assess the Efficacy and Safety of GIA632 in Participants With Non-segmental VitiligoRecruitingNCT07431177Phase 2
- Pharmacokinetics and Safety Study of Pelabresib in Patients With Advanced Malignancies and Hepatic ImpairmentRecruitingNCT07422610Phase 1
- A Study to Assess the Tolerability of Ianalumab (VAY736) With Investigator's Choice Thrombopoietin Receptor Agonist (IC TPO-RA) in Patients With Primary Immune Thrombocytopenia (ITP)RecruitingNCT07421167Phase 2
- A Study of Iptacopan in Korean Patients With Paroxysmal Nocturnal Hemoglobinuria or C3 GlomerulopathyRecruitingNCT07416162
- A Real-world Study of Remibrutinib in Chronic Spontaneous Urticaria PatientsRecruitingNCT07408219
- Safety and Efficacy of Asciminib in Pediatrics and Young Adults With Relapse/Refractory (r/r) Philadelphia Positive (Ph+) or ABL-class Ph-like Acute Lymphoblastic Leukemia (ALL)RecruitingNCT07387926Phase 1/2
- A Non-Interventional Study PASS to Characterize Secondary Malignancies of Tcell Origin Following Tisagenlecleucel TherapyRecruitingNCT07378969
- Real-world Study of Scemblix in the Treatment of Chronic Myeloid Leukemia in ChinaRecruitingNCT07375355
- Remibrutinib in Real-world Clinical Practice - a US Sub-studyRecruitingNCT07358780
- Remibrutinib in Real-world Clinical PracticeRecruitingNCT07358364
- A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)RecruitingNCT07357727Phase 3
- Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CPRecruitingNCT07354074Phase 2
- A Drug-drug Interaction Study to Evaluate the Effects of Pelabresib on the Pharmacokinetics of Repaglinide, Midazolam, and Combined Oral Contraceptive in Patients With Advanced MalignanciesRecruitingNCT07340190Phase 1
- CHART-C3G/CLNP023B12011Not yet recruitingNCT07331259